Topiramate is also found in the weight-loss drug Qnexa that is manufactured by Vivus Incorporated. This drug has been rejected by the FDA last year because of the potential for birth defects as well as other reasons. The FDA is requiring further studies on birth defects from Vivus before this drug will be marketable.
